The global Veterinary Vaccines Market Growth Accelerated by Technological Advancements


 Veterinary vaccines are biological preparations intended to produce active acquired immunity in domestic animals to infectious diseases caused by pathogens like viruses, bacteria, parasites and fungi. These vaccines help in prevention of different animal diseases like rabies, distemper, parvovirus etc. Advantages of veterinary vaccines include protection from deadly diseases, safety and affordability which has increased the demand for veterinary vaccines globally.

The global Veterinary Vaccines Market is estimated to be valued at US$ 8,482.6 Mn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Technological advancements in vaccine production have accelerated the growth of the veterinary vaccines market. Various new technologies like recombinant vector vaccines, mRNA vaccines, inactivated/killed vaccines, live attenuated vaccines and DNA vaccines have been introduced to develop efficacious and efficient vaccines. For instance, mRNA technology is being applied to develop vaccines for companion animals like dogs and cats. mRNA vaccines allow for flexible design and production which helps in quick development of vaccines against emerging pathogens. Moreover, use of adjuvants in veterinary vaccines has also improved immunogenicity and efficacy. Adjuvanted vaccines elicit longer-lasting immune responses and allow reduced vaccine doses. These technological developments have expanded the product portfolio of veterinary vaccines manufacturers and boosted market growth over the forecast period.

Segment Analysis

The global veterinary vaccines market is segmented based on technology, disease, and animal. The live attenuated vaccines segment dominates the technology segment due to higher immunity and longer duration of protection against diseases offered by these vaccines. Based on disease, the preventive vaccines sub-segment accounts for the largest share as most veterinary vaccines available in the market are disease preventive in nature. On the basis of animal, the companion animal segment has the highest market share as pets hold huge sentimental value.

Key Takeaways

The global veterinary vaccines market is expected to witness high growth over the forecast period. Rapid growth in companion animal adoption rate globally is driving the demand for veterinary vaccines. The global Veterinary Vaccines Market is estimated to be valued at US$ 8,482.6 Mn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030.


Regional analysis related content comprises:
The Asia Pacific region is expected to grow at the fastest rate owing to rising awareness about animal health and increasing per capita animal health expenditure in emerging economies like India and China. North America commanded the largest market share driven by growing pet adoption and rising per capita animal healthcare spending in the US and Canada.

Key players related content comprises:
Key players operating in the veterinary vaccines market are Aratana Therapeutics, Inc., Regeneus Ltd., Karyopharm Therapeutics, Inc., Zoetis, Inc., Eli Lilly and Company, Merck & Co., Inc., and Boehringer Ingelheim GmbH. Zoetis and Merck & Co., Inc. enjoy a dominant market position due to their diverse product portfolio and global presence.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more